Aixia Ma Selected Research

Aixia Ma Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 08/2022 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
3	Insulin Resistance 01/2020 - 01/2014
2	Surgical Wound Infection 01/2024 - 01/2020
2	Microsatellite Instability 06/2023 - 01/2023
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 05/2024
1	Heart Diseases (Heart Disease) 01/2024
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2024
1	Atrial Fibrillation 10/2023
1	Thrombosis (Thrombus) 08/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Obesity 08/2022
1	Hyperemia 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Intraabdominal Infections 01/2022
1	Seizures (Absence Seizure) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Epilepsy (Aura) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Peripheral Arterial Disease 01/2021
1	Rheumatoid Arthritis 12/2020
1	Hemorrhage 01/2020
1	Hypothermia 01/2020
1	Cushing Syndrome 02/2019
1	Carcinoid Tumor (Carcinoid) 02/2019
1	Chronic Hepatitis C 11/2018
1	Infections 11/2018
1	Fibrosis (Cirrhosis) 11/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Hypertension (High Blood Pressure) 01/2015

Drug/Important Bio-Agent (IBA)

4	sintilimabIBA 11/2022 - 01/2022
2	pembrolizumabIBA 06/2023 - 01/2023
2	regorafenibIBA 01/2023 - 01/2021
2	Bevacizumab (Avastin)FDA Link 11/2022 - 01/2022
2	C-PeptideIBA 08/2022 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2020
2	CholesterolIBA 01/2021 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2015
1	LycopeneIBA 05/2024
1	AntioxidantsIBA 05/2024
1	Ginkgo biloba extract (Rokan)IBA 05/2024
1	IsoflavonesIBA 05/2024
1	AnticoagulantsIBA 10/2023
1	nattokinaseIBA 08/2023
1	NivolumabIBA 01/2023
1	PlatinumIBA 01/2023
1	niraparibIBA 01/2023
1	anlotinibIBA 01/2023
1	lenvatinibIBA 11/2022
1	Biosimilar PharmaceuticalsIBA 11/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 08/2022
1	Thyroid HormonesIBA 08/2022
1	eravacyclineIBA 01/2022
1	Formoterol Fumarate (Oxis)FDA Link 01/2022
1	Tiotropium Bromide (Spiriva)FDA Link 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022
1	Interleukin-12 (IL 12)IBA 01/2021
1	HMPL-013IBA 01/2021
1	IntegrinsIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	perampanelIBA 01/2021
1	SteroidsIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Thrombopoietin (c-mpl Ligand)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	tofacitinibIBA 12/2020
1	Antirheumatic Agents (DMARD)IBA 12/2020
1	LipopolysaccharidesIBA 01/2020
1	Amine Oxidase (Copper-Containing)IBA 01/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2019
1	grazoprevirIBA 11/2018
1	asunaprevirIBA 11/2018
1	Antiviral Agents (Antivirals)IBA 11/2018
1	elbasvirIBA 11/2018
1	daclatasvirIBA 11/2018
1	Gefitinib (Iressa)FDA Link 01/2016
1	icotinibIBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2016
1	Pancreaticoduodenectomy 01/2024
1	Blood Transfusion (Blood Transfusions) 01/2024
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Length of Stay 01/2020